• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Andrew S. Chi


  • Chheda MG, Wen PY, Hochberg FH, Chi AS, Drappatz J, Eichler AF, Yang D, Beroukhim R, Norden AD, Gerstner ER, Betensky RA, Batchelor TT.Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.J. Neurooncol. 2014 Dec 13.
  • Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS.Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.J. Neurooncol. 2014 Nov 20.
  • Sullivan JP, Nahed BV, Madden MW, Oliveira SM, Springer S, Bhere D, Chi AS, Wakimoto H, Rothenberg SM, Sequist LV, Kapur R, Shah K, Iafrate AJ, Curry WT, Loeffler JS, Batchelor TT, Louis DN, Toner M, Maheswaran S, Haber DA.Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression.Cancer Discovery. 2014 Aug 19.
  • Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P.Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.Cancer. 2014 Sep 9.
  • Cho TA, Chi AS, Schaefer PW.Case 8-2014: A man with headache, vomiting, and diplopia.N Engl J Med. 2014 Jun 26;370(26):2545.
  • Wakimoto H, Tanaka S, Curry WT, Loebel F, Zhao D, Tateishi K, Chen J, Klofas LK, Lelic N, Kim JC, Dias-Santagata D, Ellisen LW, Borger DR, Fendt SM, Vander Heiden MG, Batchelor TT, Iafrate AJ, Cahill DP, Chi AS.Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Clin Cancer Res. 2014 Jun 1(11):2898-909.
  • Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, Beik S, Kadri S, Tirosh I, Wortman I, Shalek AK, Rozenblatt-Rosen O, Regev A, Louis DN, Bernstein BE.Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.Cell. 2014 Apr 24;157(3):580-94.
  • Cho TA, Chi AS, Schaefer PW, Louis DN.Case records of the Massachusetts General Hospital. Case 8-2014. A 29-year-old man with headache, vomiting, and diplopia.N Engl J Med. 2014 Mar 13;370(11):1049-59.
  • Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK.Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19059-64.
  • Chi AS, Chamberlain MC.Is there a role for bevacizumab in the treatment of glioblastoma?.Oncologist. 2013;18(10):1080-2.
  • Andronesi OC, Rapalino O, Gerstner E, Chi A, Batchelor TT, Cahill DP, Sorensen AG, Rosen BR.Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.J Clin Invest. 2013 Sep 3;123(9):3659-63. Review.
  • Taylor JW, Chi AS, Cahill DP.Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.Oncology (Huntingt). 2013 Jun;27(6):504-14. Review.
  • Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK.Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.Neuro Oncology. 2013 Aug;15(8):1079-87.
  • Rheinbay E, Suvà ML, Gillespie SM, Wakimoto H, Patel AP, Shahid M, Oksuz O, Rabkin SD, Martuza RL, Rivera MN, Louis DN, Kasif S, Chi AS, Bernstein BE.An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.Cell Rep. 2013 May 30;3(5):1567-79.
  • Chi AS, Batchelor TT, Yang D, Dias-Santagata D, Borger DR, Ellisen LW, Iafrate AJ, Louis DN.BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults.J Clin Oncol. 2013 May 10;31(14):e233-6.
  • Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, Wang DL, Curry WT, Wen PY, Ligon KL, Ellisen L, Louis DN, Iafrate AJ.Prospective, high-throughput molecular profiling of human gliomas.J. Neurooncol. 2012 Oct;110(1):89-98.
  • Drappatz J, Lee EQ, Hammond S, Grimm SA, Norden AD, Beroukhim R, Gerard M, Schiff D, Chi AS, Batchelor TT, Doherty LM, Ciampa AS, Lafrankie DC, Ruland S, Snodgrass SM, Raizer JJ, Wen PY.Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.J. Neurooncol. 2012 Mar;107(1):133-8.
  • Chi AS, Batchelor TT, Kwak EL, Clark JW, Wang DL, Wilner KD, Louis DN, Iafrate AJ.Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor.J Clin Oncol. 2012 Jan 20;30(3):e30-3.
  • Chi AS, Wen PY.Inhibiting angiogenesis in malignant gliomas.Handb Clin Neurol. 2012;104:279-308.
  • Coumans JV, Walcott BP, Nahed BV, Oh KS, Chi AS.Multimodal therapy of an intramedullary cervical primitive neuroectodermal tumor in an adult.J Clin Oncol. 2012 Jan 10;30(2):e15-8.
  • Mendenhall EM, Koche RP, Truong T, Zhou VW, Issac B, Chi AS, Ku M, Bernstein BE.GC-rich sequence elements recruit PRC2 in mammalian ES cells.PLoS Genet. 2010;6(12):e1001244.
  • Chi AS, Norden AD, Wen PY.Antiangiogenic strategies for treatment of malignant gliomas.Neurotherapeutics : The Journal Of The American Society For Experimental Neuro Therapeutics. 2009 Jul;6(3):513-26. Review.
  • Chi AS,Sorensen AG,Jain RK,Batchelor TT.Angiogenesis as a Therapeutic Target in Malignant Gliomas.Oncologist. 2009 Jun;14(6):621-36. Review.
  • Chi AS,Bernstein BE.Developmental biology. Pluripotent chromatin state.Science. 2009 Jan 9;323(5911):220-1.
  • Ku M,Koche RP,Rheinbay E,Mendenhall EM,Endoh M,Mikkelsen TS,Presser A,Nusbaum C,Xie X,Chi AS,Adli M,Kasif S,Ptaszek LM,Cowan CA,Lander ES,Koseki H,Bernstein BE.Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.PLoS Genet. 2008 Oct;4(10):e1000242.
  • Chi A, Norden AD, Wen PY.Inhibition of angiogenesis and invasion in malignant gliomas.Expert Rev Anticancer Ther. 2007 Nov;7(11):1537-60. Review.
  • Chi AS, Wen PY.Inhibiting kinases in malignant gliomas.Expert Opin Ther Targets. 2007 Apr;11(4):473-96. Review.
  • Chi AS,Deng Z,Albach RA,Kemp RG.The two phosphofructokinase gene products of Entamoeba histolytica.J Biol Chem. 2001 Jun 8;276(23):19974-81.
  • Chi A,Kemp RG.The primordial high energy compound: ATP or inorganic pyrophosphate?.J Biol Chem. 2000 Nov 17;275(46):35677-9.